Vaccine development is a laborious and time-consuming process and can benefit from statistical machine learning techniques, which can produce general outcomes based on the patterns observed in the limited available empirical data. In this paper, we show how limited gene expression data from a small sample of subjects can be used to predict the outcomes of malaria vaccine. In addition, we also draw inferences from the gene expression data, with over 22000 columns (or features), by visualizing the data, and reduce the data dimensions based on this inference for efficient model training. Our methods are general and reliable and can be extended to vaccines developed against any pathogen. Given the gene expression data from a sample of subjects administered with a novel vaccine, our methods can be used to test the outcome of that vaccine, without the need for empirical observations on a larger population. By carefully tuning the available data and the machine learning models, we are able to achieve greater than 98% accuracy, with sensitivity and specificity of 0.93 and 1 respectively, in predicting the outcomes of the malaria vaccine in developing immunogenicity against the malaria pathogen.
INTRODUCTION
The testing phase of the vaccine development process typically involves three stages. In the first stage, the vaccine is administered only to a small sample of subjects and provides empirical observations on the outcomes of the vaccine. The second and third stages involve randomized, single-or double-blinded efficacy testing on larger populations, with appropriate placebo controls (Sanford et al., 1993) . However, "phase 2 results can inaccurately predict safety and/or effectiveness for medical products in a wide range of diseases and patient populations" (US Food and Drug Administration, 2017) . These inaccuracies in predicting the safety and effectiveness of vaccines can lead to adverse outcomes.
The motivation for this work, therefore, is to allow data collected in the first stage, although limited, to be processed by statistical machine learning methods to produce general observations applicable to a larger population. In effect, the outcomes of the vaccine administration is estimated statistically with only the data available from the first stage of testing. The observations from the first stage can help improve the timing and safety requirements in the second and third phase trials by predicting the susceptibility of subjects to a disease after vaccination.
Gene expression data have been previously used in combination with statistical machine learning methods for medical diagnostics and risk analysis of diseases-for example, the risk of acute myeloid leukemia as studied by Wilson et al. (2006) . Related literature also describes the use of gene expression data and statistical methods in the vaccine development pipeline. Trtica-Majnaric et al. (2010) use neural networks to predict the outcomes of an influenza vaccine. However, they use blood sample analysis to predict the outcomes but not gene expression data. Gene expression data are used for vaccine responsiveness prediction by Bucasas et al. (2011) for the influenza vaccine. However, their work uses a regression model to predict the antibody responses following vaccination. This approach can be problematic: "While biomarkers have many important uses in clinical practice and product testing, most have not been shown to reliably predict clinical outcomes" (US Food and Drug Administration, 2017) .
Our methods, on the other hand, use classification models to predict whether the malaria vaccine RTS,S is effective in developing immune responses in particular subjects. RTS,S is a malaria vaccine developed by GlaxoSmithKline (Malaria Vaccine Initiative, 2017). These classification models can be used to accurately predict vaccine outcomes with given ob- servations of the gene expression data collected at particular times on a limited number of subjects. We extensively analyze the gene expression data and discover the relationships between the features (i.e., gene expression values) and the vaccine outcomes. Based on these relationships, we reduce the dimensionality of the data, choose appropriate model classes, and evaluate their performances. Specifically, we use the Logistic Regression (LR), Support Vector Machines (SVMs) and Multi-Layer Perceptron (MLP) models.
We show that our methods are reliable in predicting the outcomes of the administered vaccinewhether the vaccinated person is immunized against the disease or not-with the high accuracy of ∼ 98%, with specificity and sensitivity being 0.93 and 1 respectively. These methods can be used to efficiently train statistical models for vaccine testing with a limited number of data samples. The inferences made by these statistical models can then be used to predict the outcomes of possible vaccine trials, thus helping design better trials. 1 The rest of this document describes our methods in detail. Section 2 describes the materials and data used for our study. It discusses in detail the data tuning method to increase the generalization capability of the model and the procedure for the selection of relevant features for vaccine outcome prediction. Sections 3 briefly describes statistical machine learning models suitable for this application and the reasons for their suitability and the evaluation metrics used for assessing the performance of our methods. 4 discusses the results. Section 5 presents the conclusion.
MATERIALS
The dataset is based on expression data from a malaria vaccine trial collected by the Walter Reed Army Institute of Research (Vahey et al., 2010) . The data were originally collected in September 2009 and were updated recently in August 2018. The gene expressions are arranged in GeneChip HG-U133 Plus2.0 arrays. The GeneChip Human Genome U133A Plus 2.0 Array is a single array representing around 22,000 wellcharacterized human genes that can be used to explore human biology and disease processes (ThermoFisher, 2001) . The dataset was downloaded from the National Center for Biotechnology Information (NCBI), series number GSE18323 2 .
The dataset contains gene expression data of 39 human subjects, who were assessed at different times during the trial. The expression data were collected on the day of the third vaccination, twenty-four and seventy-two hours after vaccination, and two weeks after the vaccination. Finally, the gene expression data 5 days post-challenge with Plasmodium falciparum (the malaria pathogen) were also collected.
Out of the 39 subjects, 13 subjects showed positive vaccine outcomes and 26 showed negative vaccine outcomes. The dataset is arranged in the form of individual files that contain the gene expression data for each subject, for every stage of the study. Each file has 22,278 rows, that contains the gene expression values normalized to base 2 logarithmic scale.
Data Tuning
The limited (precisely 39) available data points are insufficient to train a generalizable machine learning model. To counter the problem of data scarcity and to achieve generalizability, we use data augmentation techniques to increase the number of data points without significantly changing the data distribution (Van Dyk and Meng, 2001) .
We augment the dataset by sampling data points from a normal distribution and adding a minuscule amount of noise to each of the attributes as suggested by Van Dyk and Meng (2001) . This is repeated for data available at every time instance: the day of vaccination, 24 hours, 72 hours and two weeks after vaccination. Noise is sampled from a uniform distribution in the range 0 to 0.01. The value of the noise terms is small enough so that the attributes still correspond to the class labels. The range for the uniform distribution is empirically selected, so that the added noise does not drastically change the data points and the models do not overfit the data.
Adding noise does not affect the quality of the data because real-world data has unavoidable noise from the instruments that are used to collect the data. By adding noise explicitly to our attributes, the model can be made more robust and generalizable. The noise term should avoid adding bias and should be independent of other noise terms (Zhu and Wu, 2004) .
A large number of data points should not be created by adding noise. If a large number of synthetic data points were created, these data points would saturate the model, which would overfit the data. While adding the noise term to the attributes, the ratio of the protected vs. non-protected subjects should be preserved. This further ensures that the behavior of the model trained on the augmented dataset remains similar to a model trained on the actual dataset.
After adding the noise to the data, we plot the data to see the class distribution. We select three dimensions out of 22, 278 features to plot a threedimensional scatter plot. Figure 1 shows feature clusters in a three-dimensional subspace of the 22,278-dimensional feature space for the two different classes-positive vaccine outcomes and negative outcomes. Although plotted for three dimensions sampled uniformly, this plot is general in nature and holds for any three features selected from the distribution of all features. Red dots denote data points showing positive outcomes and blue dots denote data points with negative outcomes. It is evident from this figure that the feature clusters are highly overlapping for the chosen set of three features. A three-dimensional space is therefore not suitable for further analysis, and statistical methods must employ a larger number of dimensions to achieve separability of classes. The feature space is extremely highdimensional and the separability in high-dimensional space can only be analyzed using statistical methods. We show that in a feature space of dimensions as high as 700, the classes are linearly separable. The high dimensionality of the data, with 22,278 attributes, increases the training time and also increases the risk of overfitting.
Feature Selection
Feature selection methods help with these problems by reducing the dimensions without much loss of the total information. They also help to better understand the features and their relationship with the target variable. Feature selection methods have also been shown to increase the prediction accuracy of some models (Guyon and Elisseeff, 2003) .
Two schemes were used to select features from the entire feature space: Principal Component Analysis (PCA-features) and sampling of features based on a normal distribution (sampled features).
PCA is used to reduce the dimensionality of a large set of variables to obtain a smaller set that still contains most of the information in the large set. It works by finding the direction of maximum variances in the dataset and then projecting the data points in the space spanned by these directions (Jolliffe, 2011) .
The feature sampling scheme works by sampling features from a uniform distribution of the complete set of features. For every feature, the scheme either selects it or not, so the search space for the features is exponential in the number of features (Dash and Liu, 1997) . We use a sample of 719 features, this being the minimum number of features required for class separability. The number of features to be sampled is a hyperparameter and is chosen empirically based on training results. The model is then trained for every set of sampled features and the accuracy score is evaluated. The set of features that produced the best accuracy score are then stored and used to train a new model to make the necessary predictions.
The features are visualized in a pair plot as shown in Figure 2 . A pair plot is used to visualize both the distributions of single variables and the relationships between two variables. Pair plots can also help identify trends in the dataset and find the set of features that are highly correlated with the target variable. From Figure 2 it can be observed that there exists a separation between the classes. The attributes that were used to visualize the data were selected from the feature space using the feature sampling scheme.
METHODS
To predict the outcomes of the malaria vaccination, various machine learning models were explored. The augmented gene expression values before the stage where the subjects were challenged with Plasmodium falciparum (Pf), were all combined to form the training set for the model. This was done so that the models that were being trained can also learn how the outcomes of the vaccine changes with time. The gene expression values after the challenge with Pf were used as the test set. Thus the training set contained 229 data points and the test set contained 51 data points.
Support Vector Machines
Support Vector Machines (SVMs) have been the core of numerous domains such as bioinformatics studies, molecular genetics, DNA, data mining and psychiatry (Touati et al., 2018) .
In order to predict the outcome of the malaria vaccine, we use the SVM classification method which aims to find the optimal hyperplane that separates two different classes. We also used the kernel trick in SVM to make the predictions-the kernel function k(x) projects the data points to a higher dimensional feature space where the data points may be linearly separable. We use two variants of kernel functionlinear kernel (Linear-SVM) and RBF kernel (RBF-SVM). The RBF kernel tries to separate the classes using a nonlinear separator, whereas the linear kernel tries to fit a linear separator. In general, the RBF kernel is more powerful than the linear kernel (Hsu et al., 2016) .
For each of these variants, we train three different SVM models-first using all features, the second and third using PCA-features and sampled features as described in Section 2.2.
The SVMs learn the best hyperplane that separates the classes into the projected features space. At the time of prediction, the class labels are assigned based on which side of the hyperplane the point is present on. For every trained model, the necessary evaluation parameters, described later, were recorded.
Logistic Regression
The aim of the Logistic Regression (LR) model was to capture the linear relationship between the target variables and the attributes. The LR model can only capture the linear relationship between the input vector and the target variable because the hyperplane that it creates to separate the classes is formed by taking linear combinations of the input vector (Trtica-Majnaric et al., 2010) .
To predict the outcomes of the vaccine, three LR models were tested. One of the LR models was tested on all of the features that are available in the dataset. The second was tested only on the features that were extracted as described in Section 2.2 by the sampling scheme (sampled features), and the third on the PCAfeatures. At the output a binary variable was used, with 0 representing the set of subjects that had negative vaccine outcomes, and 1 representing the set of subjects that showed positive vaccine outcomes.
Multi-Layer Perceptrons
Three Multi-Layer Perceptrons (MLPs) were trained to predict the outcomes of the vaccine. All the MLPs consisted of 200 hidden layers. The initial learning rate for the gradient descent algorithm was set as 0.001 and was adjusted after every iteration. The maximum number of training epochs for all the MLPS was set to 500. The MLP models were trained on the entire feature set available in the dataset.
The MLPs differed from one another in the activation functions used to introduce non-linearity. The activation functions that were used to train the MLPs were ReLU activation, tanh activation, and logistic activation. The ReLU activation function is a halfrectified non-linearity; it is linear for positive values and zero otherwise (Zhang and Woodland, 2015) . The tanh activation function is a re-scaled version of the logistic activation function, i.e., the output range of tanh from -1 to 1 is a scaled version of the output range of the logistic activation over the range from 0 to 1 (Karlik and Olgac, 2011) . Different activation functions were used to see if the evaluation parameters change with the change in the activation function.
MLPs were used because they make no prior assumptions concerning the data distribution. They can model highly non-linear functions and can be trained to accurately generalize when presented with new data (Gardner and Dorling, 1998) . These features of MLPs make their use a very good alternative to other statistical approaches. It has been shown that MLPs can be trained to approximate virtually any smooth function (Hornik et al., 1989) .
Evaluating Model Performance
To evaluate the performances of the models, the mean accuracy score was recorded for every model. In addition to the mean accuracy score, we also calculate the positive hit rate and the negative hit rate to better compare the models based on their predictions. The positive hit rate is also called model sensitivity, while the negative hit rate is called model specificity. These two quantities are important for investigating the ability of a model to accurately recognize positive and negative outcomes (Trtica-Majnaric et al., 2010) . The sensitivity is computed as follows:
where a is the number of true positives, and d is the number of false negatives. The specificity is calculated as follows:
where b is the number of true negatives, and c is the number of false positives. Any model with high sensitivity can be used to identify the subjects with the successful administration since a model with high sensitivity can correctly identify the subjects showing positive outcomes. A model with a high specificity can be used to confirm the test results since it is more specific in recognizing the subjects that are not affected by the vaccine. In general, a good model should have high values for both sensitivity and specificity (Simon and Boring, 1990) .
The true positive and false positive rates were also used to plot the Receiver Operating Characteristic (ROC) curve and calculate the area under the curve (AUC). An ROC curve is a graph showing the performance of a classification model at all classification thresholds, and the AUC measures discrimination (Hanley and McNeil, 1982) . Discrimination is the ability of a model to correctly classify those with and without the effects of the vaccine. Table 1 shows the evaluation of the LR, SVM and MLP models with variations: different subsets of features for LR, SVM, and MLP, linear or non-linear separation for SVM, and various activation functions for MLPs. The best performing model with the highest mean accuracy score of 98.03% is the LR model trained with the sampled features. This model also has high specificity and sensitivity values, 0.93 and 1 respectively. It is also the most efficient in the sense that it uses only a subset of features (and not all features) in the training data to make inferences on test data. The Linear-SVM model using all features also has high mean accuracy score, sensitivity and specificity of 96.07%, 0.87 and 1 respectively. These values are only slightly lower than the best model, but this level of accuracy is achieved after training on the whole set of features, unlike the LR model which uses only a subset of features. The MLP models with different activation functions were also tested on the features given by PCA as well as on the sampled features, but the mean accuracy was very low and thus these models have not been reported here. Tables 3 shows the sensitivities, specificities, false positives and false negatives of the LR models using all features and sampled features respectively. Similarly, Table 4 shows these four values for the SVM models trained using all features and sampled features. The false positive rates (with actual outcome 0 and predicted outcome 1) and the false negative rates (with actual outcome 1 and predicted outcome 0) are low for all of these models. The best LR model trained with sampled features also gives the lowest false negative rate of 0.07.
RESULTS AND DISCUSSION

Evaluation Metrics
Comparison of Linear and Non-Linear Models
It is evident from Table 1) , which is a significant difference. Due to overfitting, these models tend to classify all samples to the positive outcome class, hence resulting in a specificity of 1, with 0 sensitivity. Thus, we have shown empirically that the data points are linearly separable in the sampled feature space consisting of over 700 features and the complete feature space with over 22000 features. However, the data points are not separable in a lowerdimensional space (for example, the 3-dimensional feature space shown in Figure 1 ). In that case, the features are undersampled.
Effect of Feature Selection
The mean prediction accuracy of the LR model increases when it is trained only on the sampled features (Table 1 ). This indicates that there are some features present in the entire feature space that are not highly correlated with the target variable, and if these features were considered, the model may misclassify leading to lower prediction accuracy. The LR model trained on the sampled features has a higher sensitivity score, and hence is better to find the subjects positively affected by the vaccine, than the LR model trained on all of the features.
The Linear-SVM models do not demonstrate a similar boost in the performance when trained only on the sampled features. Table 1 shows that the mean accuracy for the model trained only on the sampled features is slightly lower than the model trained on the entire feature set.
However, the Linear-SVM model trained only on the sampled features had the highest sensitivity of all the models evaluated. This model is the best when the requirement is to find the subjects positively affected by the vaccine. The high sensitivities for both the LR and Linear-SVM models trained on the sampled features suggest that the feature set that was used to train these models is better than the entire feature set, for predicting the positive outcomes of the vaccine.
The models trained on the PCA-features do not perform as well as the other models. The sensitivity and specificity for these models are also very low. Thus, the features extracted with the PCA scheme, that is the directions of maximum variances, are not suitable for estimating the target variables.
ROC and AUC
For the linear models, the ROC curves were plotted and the area under the curve (AUC) was also computed. The AUC is classification-threshold-invariant, and measures the quality of the model's predictions irrespective of what classification threshold is chosen (Hanley and McNeil, 1982) . The higher the AUC, the better the model in distinguishing a positive example from a negative one. Table 2 gives the area under the ROC curve for the different models. The LR model trained on the sampled feature set has the highest AUC, indicating that it distinguish between the two classes with a very high probability. The AUC for the Linear-SVM trained on the sampled features is higher than the AUC of the Linear-SVM trained on all of the features, which on account of the higher sensitivity of the first model. sparsity of data points. The dashed line in the figures represents the threshold AUC, which is 0.5. A model with AUC less than the threshold is no better than randomly assigning class labels (Hanley and Mc-Neil, 1982) .
CONCLUSION
In this paper, we have used gene expression data to predict the outcomes of a vaccine trial, with malaria as the exemplar. Prior works have tried to predict the outcomes of vaccine trials (e.g., for influenza), but have not used gene expression data to do so. Our work builds machine learning models to predict, with high accuracy, the test outcomes of a malaria vaccine from the gene expression data. The models we present are able to predict the outcomes of the vaccine with a mean accuracy of 98.03%. Such a high prediction accuracy indicates that the study of gene expressions can be successfully used to accurately predict the outcomes of the malaria vaccine. The models also have a high sensitivity and specificity values, i.e., the same model can be used to correctly identify subjects that had a positive reaction to the vaccine as well as subjects who did not respond to the vaccine.
The models described in this paper can be applied in real-world vaccine trials to screen human subjects and predict the outcomes of the vaccine. Our models can be used in conjunction with standard procedures to improve safety and/or effectiveness of vaccine trials. Using the models, we also find that some of the gene expression attributes are more useful than others, in predicting vaccination outcomes. These gene expression attributes which are highly correlated with the class labels can be used to design better vaccines, which may be effective for larger populations. Our models can also be used to assist other primary health care research that considers the outcomes of vaccine trials.
The methods used in this paper are not limited to predicting the outcomes of the malaria vaccine-they can also be used to predict the outcomes for any vaccine for which the gene expression data are available in the HG-U133 Plus2.0 format. The feature selection scheme (Section 2.2) can be used to find the gene expression attributes that are better correlated with the target variable for any particular vaccine for which predictions are to be made. Along with feature selection schemes, non-linear models such as MLP can be used where appropriate, to capture complex relationships (in case of some other diseases) between the gene expression data and the vaccine outcomes.
